Dr Gabe Kalmar

Guest Contributor
July 29, 2004

Dr Gabe Kalmar has been appointed Genome British Columbia’s executive director operations. Kalmar has a long track record of private sector experience in the pharmaceutical industry, most recently as a consultant working with several early-stage companies in the areas of technology development, merger and acquisition planning and operations. From 1996 to 2002, he held senior positions at Kinetek Pharmaceuticals Inc before the firm was acquired by QLT Inc earlier this year. Kalmar holds a BSc from the Univ of British Columbia and a PhD in biology from Simon Fraser Univ….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.